Page 57 - INSTITUTE FOR MEDICAL RESEARCH ANNUAL REPORT 2020

IMR Annual Report 2020 41

PRINCIPAL
NO. RESEARCH TITLE NMRR NUMBER INVESTIGATOR (PI)
OR CO-PRINCIPAL
INVESTIGATOR (CO-PI)
Identification and onset of antimalarial drug
resistance gene mutation from blood samples
27 of human infected with Plasmodium spp. and NMRR-17-757-35548 Dr Noor Azian Md Yusuf
(PI)
previously treated with antimalarial combination
therapy
Molecular epidemiology of asymptomatic
28 NMRR-19-470-47341 Adela Ida Jiram (PI)
submicroscopic malaria in Malaysia
Prospective cohort study of women exposed to Dr Ravindran Thayan
29 NMRR-18-803-41164
Zika virus during the course of pregnancy (PI)
Dr Rozainanee Binti
30 Development of inactivated COVID-19 vaccine NMRR-20-1956-55005
Mohd Zain (PI)
Prevalence of hepatitis D virus among HBsAg Research Centre (IDRC) Infectious Diseases
31 positive patients in Malaysia and development NMRR-19-3502-51677 Dr Rozainanee Binti
Mohd Zain (PI)
of HCV genotyping assay
Molecular characterisation of SARS-CoV-2 by
32 NMRR -20-884-54816 Dr Jeyanthi Suppiah (PI)
whole genome sequencing
Identification of platelet transcriptome
y
I)
(P
an
D
J
e
r
33 biomarkers in dengue infection to complement NMRR-19-1691-48343
t
upp
i
S
hi
ah
existing diagnostic algorithm
Evaluation of potential antiviral activity of Dr Jeevanathan
34 NMRR-19-3150-51531
ravidasvir against dengue virus Kalyanasundram (PI)
Detection of co-infection/infection of Influenza Tengku Rogayah
A viruses in SARI patients and potential
35 NMRR-16-2766-32218 Tengku Abdul Rashid
involvement of mutants associated with (PI)
increased severity
Elucidating the molecular taxonomy of Tengku Rogayah
virulence factor in dengue virus in Malaysia and
36 PhD project Tengku Abdul Rashid
identification of biomarkers for dengue severe (Co-PI)
cases through NGS
In vivo anti-dengue study of Schizophyllum
37 NMRR-17-2801-39102 Kavithambigai Ellan (PI)
commune aqueous extract in AG129 mice
Tengku Rogayah
Interrogating novel antiviral compounds against Inter-agency
38 Tengku Abdul Rashid
DENV via inhibition of host glycolytic pathway collaboration
(Co-PI)